@article{33ce72f337b24cd29d66bcfc63c0e257,
title = "ZMYND8 is a primary HIF coactivator that mediates breast cancer progression",
abstract = "Epigenetic regulator plays a pivotal role in breast cancer progression. We recently demonstrated that the epigenetic reader zinc finger MYND-type containing 8 (ZMYND8) mediates breast cancer progression and metastasis by activating hypoxia-inducible factor (HIF). This discovery provides new insights into the molecular mechanism underlying HIF activation and breast cancer progression.",
keywords = "Hypoxia-inducible factor, breast cancer, epigenetic reader, gene regulation",
author = "Yan Chen and Yingfei Wang and Weibo Luo",
note = "Funding Information: This work was supported by grants from Susan G. Komen (CCR16376227), NIH (R00CA168746), the Cancer Prevention & Research Institute of Texas (CPRIT, RR140036), Welch Foundation (I-1903-20160319), and the American Cancer Society/UTSW Simmons Cancer Center (ACS-IRG-02-196) to WL, and grants from NIH (R00NS078049, R35GM124693), CPRIT (RP170671), and Welch Foundation (I-1939-20170325) to YW. W.L. is a CPRIT Scholar in Cancer Research. Publisher Copyright: {\textcopyright} 2018, {\textcopyright} 2018 The Author(s). Published by Taylor & Francis Group, LLC.",
year = "2018",
month = jul,
day = "4",
doi = "10.1080/23723556.2018.1479619",
language = "English (US)",
volume = "5",
journal = "Molecular and Cellular Oncology",
issn = "2372-3556",
publisher = "Taylor and Francis Ltd.",
number = "4",
}